Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
- PMID: 29928130
- PMCID: PMC6001835
- DOI: 10.2147/OTT.S157724
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Abstract
Several members of the sirtuin (SIRT) family, a highly conserved family of NAD+-dependent enzymes, have been shown to play a critical role in both promoting and/or suppressing tumorigenesis. In this study, recent progress in the field concerning SIRT4 and cancer was reviewed, and the relationship between SIRT4 and tumors was investigated. Subsequently, we evaluated the role of SIRT4 with oncogenic or tumor-suppressive activity in cancer, which may provide insight in identifying the underlying mechanism of action of SIRT4 in cancer. Finally, we explored the potential of SIRT4 as a therapeutic target in cancer therapy.
Keywords: SIRT4; cancer; genetic instability; metabolism; sirtuin.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
The Roles of Mitochondrial SIRT4 in Cellular Metabolism.Front Endocrinol (Lausanne). 2019 Jan 7;9:783. doi: 10.3389/fendo.2018.00783. eCollection 2018. Front Endocrinol (Lausanne). 2019. PMID: 30666234 Free PMC article. Review.
-
SIRT4 is upregulated in breast cancer and promotes the proliferation, migration and invasion of breast cancer cells.Int J Clin Exp Pathol. 2017 Dec 1;10(12):11849-11856. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966549 Free PMC article.
-
SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.Sci Rep. 2022 Jul 16;12(1):12208. doi: 10.1038/s41598-022-16610-8. Sci Rep. 2022. PMID: 35842463 Free PMC article.
-
Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.Oncol Rep. 2016 May;35(5):2801-10. doi: 10.3892/or.2016.4685. Epub 2016 Mar 17. Oncol Rep. 2016. PMID: 26986234
-
Functions of mammalian SIRT4 in cellular metabolism and research progress in human cancer.Oncol Lett. 2020 Oct;20(4):11. doi: 10.3892/ol.2020.11872. Epub 2020 Jul 15. Oncol Lett. 2020. PMID: 32774484 Free PMC article. Review.
Cited by
-
The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.Int J Mol Sci. 2023 Apr 27;24(9):7925. doi: 10.3390/ijms24097925. Int J Mol Sci. 2023. PMID: 37175631 Free PMC article. Review.
-
The Roles of Mitochondrial SIRT4 in Cellular Metabolism.Front Endocrinol (Lausanne). 2019 Jan 7;9:783. doi: 10.3389/fendo.2018.00783. eCollection 2018. Front Endocrinol (Lausanne). 2019. PMID: 30666234 Free PMC article. Review.
-
Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis.Biomolecules. 2022 Aug 5;12(8):1079. doi: 10.3390/biom12081079. Biomolecules. 2022. PMID: 36008973 Free PMC article. Review.
-
Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.Pharmacol Ther. 2019 Aug;200:27-41. doi: 10.1016/j.pharmthera.2019.04.002. Epub 2019 Apr 8. Pharmacol Ther. 2019. PMID: 30974124 Free PMC article. Review.
-
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype.Front Pharmacol. 2019 Jan 30;10:38. doi: 10.3389/fphar.2019.00038. eCollection 2019. Front Pharmacol. 2019. PMID: 30761005 Free PMC article. Review.
References
-
- Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403(6771):795–800. - PubMed
-
- Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 2000;273(2):793–798. - PubMed
-
- Saunders LR, Verdin E. Cell biology. Stress response and aging. Science. 2009;323(5917):1021–1022. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources